ReviewBiomedicines2022

The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview.

Irene Veneziani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.